Overview
Equal-risk-weighted alternative to market-cap US equity indexing. Stratifies the S&P 500 by business risk across 6 dimensions rather than market cap. Reduces FAANG/mega-cap concentration. More balanced sector exposure.
Top Holdings
| Ticker | Holding | Weight |
|---|---|---|
| JNJ | Johnson & Johnson | 2.4% |
| PG | Procter & Gamble | 2.2% |
| JPM | JPMorgan Chase | 2.0% |
| UNH | UnitedHealth Group | 1.9% |
| HD | Home Depot | 1.8% |
| XOM | Exxon Mobil | 1.8% |
| ABBV | AbbVie Inc. | 1.7% |
| CVX | Chevron Corp. | 1.7% |
| KO | Coca-Cola | 1.6% |
| MRK | Merck & Co. | 1.6% |
Fund Details
Investment Thesis
SAMT uses Syntax's proprietary stratification methodology to weight S&P 500 stocks by business risk rather than market capitalization. The methodology categorizes each company across six business dimensions — products, customers, suppliers, competitors, partners, and regulators — then weights them to achieve balanced risk exposure across each dimension. The result reduces the extreme mega-cap technology concentration of standard cap-weighted S&P 500 ETFs while maintaining diversified exposure to the same underlying companies. This provides a systematic way to own the S&P 500 without the concentration risk that has made VOO and SPY heavily FAANG-dependent.
Who It's For
Investors who want S&P 500 exposure without the extreme concentration in mega-cap technology stocks that market-cap weighting creates. SAMT suits those who believe equal-risk weighting provides better long-term risk-adjusted returns than cap-weighting when technology valuations are extended, and those who want more balanced sector exposure within US large-cap equity. Best used as an alternative or complement to standard cap-weighted S&P 500 funds.
10-Year History
| Year | Close | % Chg |
|---|---|---|
| 2016 | -- | -- |
| 2017 | -- | -- |
| 2018 | -- | -- |
| 2019 | $24.82 | -- |
| 2020 | $26.42 | +6.4% |
| 2021 | $34.82 | +31.8% |
| 2022 | $28.42 | -18.4% |
| 2023 | $34.42 | +21.1% |
| 2024 | $34.82 | +1.2% |
| 2025 | $39.98 | +14.8% |
| Year | Yield |
|---|---|
| 2016 | -- |
| 2017 | -- |
| 2018 | -- |
| 2019 | 1.22% |
| 2020 | 1.12% |
| 2021 | 1.02% |
| 2022 | 1.18% |
| 2023 | 1.08% |
| 2024 | 1.12% |
| 2025 | 1.22% |
| Year | AUM | % Chg |
|---|---|---|
| 2016 | -- | -- |
| 2017 | -- | -- |
| 2018 | -- | -- |
| 2019 | $0.1B | -- |
| 2020 | $0.2B | +100.0% |
| 2021 | $0.3B | +50.0% |
| 2022 | $0.3B | 0.0% |
| 2023 | $0.3B | 0.0% |
| 2024 | $0.3B | 0.0% |
| 2025 | $0.32B | +6.7% |
Historical figures are ETFHub estimates modelled from asset-class return patterns and may differ from official fund records. Data as of August 2026.
Related US Broad Market ETFs
Markets. Intelligence. Daily.
Full briefs on 400+ ETFs, curated daily ETF news, and a free weekly deep-dive newsletter — all on ETFHub.
Get the Free Weekly Brief Explore the ETF Portal Official Fund Page →